Differences in genetic background influence the induction of innate and acquired immune responses in chickens depending on the virulence of the infecting infectious bursal disease virus (IBDV) strain

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 79-92

  Aricibasi, Merve ^a   Jung, Arne ^a   Heller, E Dan ^b   Rautenschlein, Silke ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bioactive cytokines; Genetic background; Infectious bursal disease virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRITE; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARTICLE; BROILER; CELL POPULATION; CELL STIMULATION; CHICKEN; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EMBRYO; FLOW CYTOMETRY; GENETIC RESOURCE; HISTOPATHOLOGY; IMMUNOGENETICS; INFECTION SENSITIVITY; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; INNATE IMMUNITY; INOCULATION; MORTALITY; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; SPECIES DIFFERENCE; UPREGULATION; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, VIRAL; BIRNAVIRIDAE INFECTIONS; BURSA OF FABRICIUS; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, INNATE; INFECTIOUS BURSAL DISEASE VIRUS; INTERFERON-GAMMA; INTERFERONS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LYMPHOCYTE COUNT; MACROPHAGES; POULTRY DISEASES;

AVES; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 77951205132     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.11.005     Document Type: Article

References (51)

1. Abdul-Careem M.F., Read L.R., Parvizi P., Thanthrige-Don N., Sharif S. Marek's disease virus-induced expression of cytokine genes in feathers of genetically defined chickens. Dev. Comp. Immunol. 2008, 33:618-623.
2. Ahmed K.A., Saxena V.K., Ara A., Singh K.B., Sundaresan N.R., Saxena M., Rasool T.J. Immune response to Newcastle disease virus in chicken lines divergently selected for cutaneous hypersensitivity. Int. J. Immunogenet. 2007, 34:445-455.
3. Asif M., Lowenthal J.W., Ford M.E., Schat K.A., Kimpton W.G., Bean A.G. Interleukin-6 expression after infectious bronchitis virus infection in chickens. Viral Immunol. 2007, 20:479-486.
4. Block H., Meyer-Block K., Rebeski D.E., Scharr H., de Wit S., Rohn K., Rautenschlein S. A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies. Avian Pathol. 2007, 36:401-409.
5. Bumstead N., Reece R.L., Cook J.K. Genetic differences in susceptibility of chicken lines to infection with infectious bursal disease virus. Poult. Sci. 1993, 72:403-410.
6. Crippen T.L., Sheffield C.L., He H., Lowry V.K., Kogut M.H. Differential nitric oxide production by chicken immune cells. Dev. Comp. Immunol. 2003, 27:603-610.
7. de Wit S. Gumboro disease: estimation of optimal time of vaccination by the Deventer formula. Pol. Vet. J. 1998, 3:19-22.
8. Djeraba A., Musset E., van Rooijen N., Quere P. Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. Vet. Microbiol. 2002, 86:229-244.
9. Eldaghayes I., Rothwell L., Williams A., Withers D., Balu S., Davison F., Kaiser P. Infectious bursal disease virus: strains that differ in virulence differentially modulate the innate immune response to infection in the chicken bursa. Viral Immunol. 2006, 19:83-91.
10. Eterradossi N., Saif Y.M. Infectious Bursal Disease 2008, 185-208. Blackwell Publishing, Ames, IA, USA. 12th edition. Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
11. Gyorfy Z., Ohnemus A., Kaspers B., Duda E., Staehli P. Truncated chicken interleukin-1beta with increased biologic activity. J. Interferon Cytokine Res. 2003, 23:223-228.
12. Hassan M.K., Afify M., Aly M.M. Susceptibility of vaccinated and unvaccinated Egyptian chickens to very virulent infectious bursal disease virus. Avian Pathol. 2002, 31:149-156.
13. Hibbs L.B., Taintor R.R., Vavrin Z., Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 1988, 157:87-94.
14. Hudson J.C., Hoerr E.J., Parker S.H., Ewald S.J. Quantitative measures of disease in broiler breeder chicks of different major histocompatibility complex genotypes after challenge with infectious bursal disease virus. Avian Dis. 2002, 46:581-592.
15. Hussain I., Qureshi M.A. Nitric oxide synthase activity and mRNA expression in chicken macrophages. Poult. Sci. 1997, 76:1524-1530.
16. Jarosinski K.W., Njaa B.L., O'Connell P.H., Schat K.A. Pro-inflammatory response in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunol. 2005, 18:148-161.
17. Jung, A., 2006. Pathogenesestudie eines intermediärvirulenten Gumborovirus in spezifiziert-pathogen-freien (SPF) Hühnern und kommerziellen Broilern. Doctoral Thesis. University of Veterinary Medicine, Hannover, Germany.
18. Juul-Madsen H.R., Dalgaard T.S., Rontved C.M., Jensen K.H., Bumstead N. Immune response to a killed infectious bursal disease virus vaccine in inbred chicken lines with different major histocompatibility complex haplotypes. Poult. Sci. 2006, 85:986-998.
19. Karaca K., Sharma J.M., Tomai M.A., Miller R.L. In vivo and in vitro interferon induction in chickens by S-28828, an imidazoquinolinamine immunoenhancer. J. Interferon Cytokine Res. 1996, 16:327-332.
20. Khatri M., Palmquist J.M., Cha R.M., Sharma J.M. Infection and activation of bursal macrophages by virulent infectious bursal disease virus. Virus Res. 2005, 113:44-50.
21. Kim I.J., Gagic M., Sharma J.M. Recovery of antibody-producing ability and lymphocyte repopulation of bursal follicles in chickens exposed to infectious bursal disease virus. Avian Dis. 1999, 43:401-413.
22. Kim I.J., Sharma J.M. IBDV-induced bursal T lymphocytes inhibit mitogenic response of normal splenocytes. Vet. Immunol. Immunopathol. 2000, 74:47-57.
23. Kim I.J., You S.K., Kim H., Yeh H.Y., Sharma J.M. Characteristics of bursal T lymphocytes induced by infectious bursal disease virus. J. Virol. 2000, 74:8884-8892.
24. Kochs G., Koerner I., Thiel L., Kothlow S., Kaspers B., Ruggli N., Summerfield A., Pavlovic J., Stech J., Staeheli P. Properties of H7N7 influenza A virus strain SC35 M lacking interferon antagonist NS1 in mice and chickens. J. Gen. Virol. 2007, 88:1403-1409.
25. Lynagh G.R., Bailey M., Kaiser P. Interleukin-6 is produced during both murine and avian Eimeria infections. Vet. Immunol. Immunopathol. 2000, 76:89-102.
26. MacMiking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
27. Mo C.W., Cao Y.C., Lim B.L. The in vivo and in vitro effects of chicken interferon alpha on infectious bursal disease virus and Newcastle disease virus infection. Avian Dis. 2001, 45:389-399.
28. Palmquist J.M., Khatri M., Cha R.M., Goddeeris B.M., Walcheck B., Sharma J.M. In vivo activation of chicken macrophages by infectious bursal disease virus. Viral Immunol. 2006, 19:305-315.
29. Pitcovski J., Cahaner A., Heller E.D., Zouri T., Gutter B., Gotfried Y., Leitner G. Immune response and resistance to infectious bursal disease virus of chicken lines selected for high or low antibody response to Escherichia coli. Poult. Sci. 2001, 80:879-884.
30. Qureshi M.A. Avian macrophage and immune response: an overview. Poult. Sci. 2003, 82:691-698.
31. Rautenschlein S., Yeh H.Y., Njenga M.K., Sharma J.M. Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery. Arch. Virol. 2002, 147:285-304.
32. Rautenschlein S., Yeh H.Y., Sharma J.M. The role of T cells in protection by an inactivated infectious bursal disease virus vaccine. Vet. Immunol. Immunopathol. 2002, 89:159-167.
33. Rautenschlein S., Yeh H.Y., Sharma J.M. Comparative immunopathogenesis of mild, intermediate, and virulent strains of classic infectious bursal disease virus. Avian Dis. 2003, 47:66-78.
34. Rautenschlein S., Kraemer C., Vanmarcke J., Montiel E. Protective efficacy of intermediate and intermediate plus infectious bursal disease virus (IBDV) vaccines against very virulent IBDV in commercial broilers. Avian Dis. 2005, 49:231-237.
35. Rautenschlein S., von Samson-Himmelstjerna G., Haase C. A comparison of immune response to infection with virulent infectious bursal disease virus (IBDV) between specific-pathogen-free chickens infected at 12 and 28 days of age. Vet. Immunol. Immunopathol. 2007, 115:251-260.
36. Rauw F., Lambrecht B., van den Berg T. Pivotal role of ChIFNgamma in the pathogenesis and immunosuppression of infectious bursal disease. Avian Pathol. 2007, 36:367-374.
37. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
38. Rodenberg J., Sharma J.M., Belzer S.W., Nordgren R.M., Naqi S. Flow cytometric analysis of B cell and T cell subpopulations in specific-pathogen-free chickens infected with infectious bursal disease virus. Avian Dis. 1994, 38:16-21.
39. Ruby T., Whittaker C., Withers D.R., Chelbi-Alix M.K., Morin V., Oudin A., Young J.R., Zoorob R. Transcriptional profiling reveals a possible role of the timing of the inflammatory response in determining susceptibility to a viral infection. J. Virol. 2006, 80:9207-9216.
40. Schat K.A., Xing Z. Specific and nonspecific immune response to Marek's disease virus. Dev. Comp. Immunol. 2000, 24:201-221.
41. Schmidt H.H., Wilke P., Evers B., Bohme E. Enzymatic formation of nitrogen oxides from l-arginine in bovine brain cytosol. Biochem. Biophys. Res. Commun. 1989, 165:284-291.
42. Sharma J.M., Dohms J.E., Metz A.L. Comparative pathogenesis of serotype 1 and variant serotype 1 isolates of infectious bursal disease virus and their effect on humoral and cellular immune competence of specific-pathogen-free chickens. Avian Dis. 1989, 33:112-124.
43. Sommer F., Cardona C. Chicken anemia virus in broilers: dynamics of the infection in two commercial broiler flocks. Avian Dis. 2003, 47:1466-1473.
44. Tanimura N., Sharma J.M. Appearance of T cells in the bursa of Fabricius and cecal tonsils during the acute phase of infectious bursal disease virus infection in chickens. Avian Dis. 1997, 41:638-645.
45. Watanabe T. Polymorphism of the chicken antiviral MX gene. Cytogenet. Genome Res. 2007, 117:370-375.
46. Winterfield R.W., Fadly A.M., Bickford A. Infectivity and distribution of infectious bursal disease virus in the chicken. Persistence of the virus and lesions. Avian Dis. 1972, 16:622-632.
47. Wong R.T., Hon C.C., Zeng F., Leung F.C. Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays. J. Gen. Virol. 2007, 88:1785-1796.
48. van den Berg T.P. Acute infectious bursal disease in poultry: a review. Avian Pathol. 2000, 29:175-194.
49. Yeh H.Y., Rautenschlein S., Sharma J.M. Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies. Vet. Immunol. Immunopathol. 2002, 89:149-158.
50. Yunis R., Ben-David A., Heller A.D., Cahaner A. Genetic and phenotypic correlations between antibody responses to Escherichia coli, infectious bursal disease virus (IBDV), and Newcastle disease virus (NDV), in broiler lines selected on antibody response to Escherichia coli. Poult. Sci. 2002, 81:302-308.
51. Zhou J., Smith D.K., Lu L., Poon V.K., Ng F., Chen D.Q., Huang J.D., Yuen K.Y., Cao K.Y., Zheng B.J. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J. Viral Hepat. 2008, 16:45-52.